Search research articles
Contact Us
Filters
Showing results (61-70 of 80) with videos related to
Page
of 8
Sort By:
Therapeutic Advances in Medical Oncology
|
May 7, 2021
Anthracycline-containing <i>versus</i> carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial
Hong-Fei Gao, Zhiyong Wu, Ying Lin, et al.
Annals of Translational Medicine
|
June 24, 2021
Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world study
Jun Ma, Huiqiang Huang, Peifen Fu, et al.
Science Advances
|
October 8, 2025
High-speed photoacoustic and ultrasonic computed tomography of the breast tumor for early diagnosis with enhanced accuracy
Keer Huang, Peifen Fu, Hengyue Zhu, et al.
Health and Quality of Life Outcomes
|
March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study
Ayong Cao, Jin Zhang, Xiaoan Liu, et al.
BMC Medicine
|
December 27, 2022
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
Jiong Wu, Zefei Jiang, Zhenzhen Liu, et al.
BMC Cancer
|
April 21, 2025
Mecapegfilgrastim prophylaxis for neutropenia in patients with non-myeloid malignancies: A Chinese nationwide real-world study
Shukui Qin, Yanxia Shi, Peifen Fu, et al.
Frontiers in Oncology
|
May 17, 2021
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
Jiujun Zhu, Dechuang Jiao, Min Yan, et al.
Iscience
|
July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study
Fengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Therapeutic Advances in Medical Oncology
|
March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy
Amina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 80) with videos related to
Sort By:
Page
of 8
Therapeutic Advances in Medical Oncology
|
May 7, 2021
Anthracycline-containing <i>versus</i> carboplatin-containing neoadjuvant chemotherapy in combination with trastuzumab for HER2-positive breast cancer: the neoCARH phase II randomized clinical trial
Hong-Fei Gao, Zhiyong Wu, Ying Lin, et al.
Annals of Translational Medicine
|
June 24, 2021
Prophylaxis of neutropenia with mecapegfilgrastim in patients with non-myeloid malignancies: a real-world study
Jun Ma, Huiqiang Huang, Peifen Fu, et al.
Science Advances
|
October 8, 2025
High-speed photoacoustic and ultrasonic computed tomography of the breast tumor for early diagnosis with enhanced accuracy
Keer Huang, Peifen Fu, Hengyue Zhu, et al.
Health and Quality of Life Outcomes
|
March 25, 2016
Health-related quality of life of postmenopausal Chinese women with hormone receptor-positive early breast cancer during treatment with adjuvant aromatase inhibitors: a prospective, multicenter, non-interventional study
Ayong Cao, Jin Zhang, Xiaoan Liu, et al.
BMC Medicine
|
December 27, 2022
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
Jiong Wu, Zefei Jiang, Zhenzhen Liu, et al.
BMC Cancer
|
April 21, 2025
Mecapegfilgrastim prophylaxis for neutropenia in patients with non-myeloid malignancies: A Chinese nationwide real-world study
Shukui Qin, Yanxia Shi, Peifen Fu, et al.
Frontiers in Oncology
|
May 17, 2021
Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer
Jiujun Zhu, Dechuang Jiao, Min Yan, et al.
Iscience
|
July 18, 2025
Application of sentinel lymph nodes biopsy tracers for breast cancer after neoadjuvant chemotherapy in China: A multicenter, real-world study
Fengjiang Qu, Tinghan Jiang, Zhenzhen Liu, et al.
Therapeutic Advances in Medical Oncology
|
March 9, 2023
Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
Heyan Chen, Amina Maimaitiaili, Zhenzhen Liu, et al.
Journal of Cancer Research and Clinical Oncology
|
May 2, 2023
Nomogram for predicting axillary upstaging in clinical node-negative breast cancer patients receiving neoadjuvant chemotherapy
Amina Maimaitiaili, Heyan Chen, Peiling Xie, et al.
Page
of 8